Published in Therap Adv Gastroenterol on January 01, 2016
Oral Supplementation with Bovine Colostrum Decreases Intestinal Permeability and Stool Concentrations of Zonulin in Athletes. Nutrients (2017) 0.75
Celiac Disease: Role of the Epithelial Barrier. Cell Mol Gastroenterol Hepatol (2017) 0.75
Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model. Ann N Y Acad Sci (2017) 0.75
Identification of Autophagy-Related Genes and Their Regulatory miRNAs Associated with Celiac Disease in Children. Int J Mol Sci (2017) 0.75
Leaky Gut As a Danger Signal for Autoimmune Diseases. Front Immunol (2017) 0.75
Celiac Disease Treatment: Is It the Chicken or the Egg Yolk? Dig Dis Sci (2017) 0.75
Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol (1993) 10.65
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med (2003) 7.80
The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol (1988) 6.27
Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol (2002) 5.51
Intestinal permeability: an overview. Gastroenterology (1995) 5.36
Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta (2007) 4.74
Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol (2002) 3.98
A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr (2007) 3.91
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut (2008) 3.52
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology (2000) 3.49
Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc (2003) 3.11
Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am J Gastroenterol (2012) 2.90
Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet (2000) 2.82
Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology (1998) 2.69
Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J Cell Biol (1986) 2.53
Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study. Aliment Pharmacol Ther (2012) 2.46
MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut (2009) 2.39
Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol (2000) 2.28
Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci (1999) 2.19
Alterations in intestinal permeability. Gut (2006) 2.17
Transmembrane proteins of tight junctions. Biochim Biophys Acta (2007) 2.02
Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology (2008) 1.98
Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr (2011) 1.96
Enteropathogenic Escherichia coli decreases the transepithelial electrical resistance of polarized epithelial monolayers. Infect Immun (1993) 1.90
IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology (2006) 1.89
Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol (2010) 1.88
Role of calcium in tight junction formation between epithelial cells. Am J Physiol (1990) 1.85
Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut (2003) 1.84
Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. Gut (1993) 1.79
Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther (2009) 1.72
Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol (2002) 1.68
Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci U S A (2005) 1.65
Zonula occludens-1 and -2 regulate apical cell structure and the zonula adherens cytoskeleton in polarized epithelia. Mol Biol Cell (2011) 1.60
Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol (2007) 1.59
The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol (1992) 1.53
Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease. J Immunol (2006) 1.51
The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. Aliment Pharmacol Ther (2007) 1.49
Classification and management of refractory coeliac disease. Gut (2010) 1.48
Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med (2007) 1.43
Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci (2009) 1.39
Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am J Physiol Gastrointest Liver Physiol (2011) 1.38
Gluten-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract (2002) 1.28
Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatr Res (1998) 1.27
Pilot study on the effect of linaclotide in patients with chronic constipation. Am J Gastroenterol (2009) 1.26
Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBS Lett (2005) 1.25
Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease. Gastroenterology (2003) 1.24
Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. Gastroenterology (2008) 1.12
A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol (2012) 1.05
Review article: coeliac disease, new approaches to therapy. Aliment Pharmacol Ther (2012) 1.04
Mechanism of interferon-gamma-induced increase in T84 intestinal epithelial tight junction. J Interferon Cytokine Res (2009) 1.03
Intentional and inadvertent non-adherence in adult coeliac disease. A cross-sectional survey. Appetite (2013) 1.03
Abnormal permeability precedes the development of a gluten sensitive enteropathy in Irish setter dogs. Gut (1991) 1.01
Food labeling: gluten-free labeling of foods. Final rule. Fed Regist (2013) 0.99
High rate of gastrointestinal symptoms in celiac patients living on a gluten-free diet: controlled study. Am J Gastroenterol (2003) 0.98
Affinity purification and partial characterization of the zonulin/zonula occludens toxin (Zot) receptor from human brain. J Neurochem (2000) 0.97
Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides (2012) 0.95
Morphological and biochemical studies of a naturally occurring enteropathy in the Irish setter dog: a comparison with coeliac disease in man. Res Vet Sci (1984) 0.95
Increased gastric and intestinal permeability in patients with Crohn's disease. Am J Gastroenterol (1997) 0.95
EGF receptor transactivation and MAP kinase mediate proteinase-activated receptor-2-induced chloride secretion in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2007) 0.95
Paracellular versus transcellular intestinal permeability to gliadin peptides in active celiac disease. Am J Pathol (2011) 0.93
Electrophysiological characterization of claudin ion permeability using stably transfected epithelial cell lines. Methods Mol Biol (2011) 0.90
Larazotide acetate promotes tight junction assembly in epithelial cells. Peptides (2012) 0.87
Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology (2015) 0.86
Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer. Int J Pharm (2008) 0.85
Detecting celiac disease in your patients. Am Fam Physician (1998) 0.83
Increased bacterial translocation in gluten-sensitive mice is independent of small intestinal paracellular permeability defect. Dig Dis Sci (2011) 0.82
Measuring size-dependent permeability of the tight junction using PEG profiling. Methods Mol Biol (2011) 0.81
Pathways of gliadin transport in celiac disease. Ann N Y Acad Sci (2009) 0.81
Reduced quality of life in coeliac disease is more strongly associated with depression than gastrointestinal symptoms. J Psychosom Res (2013) 0.80
It is the compliance, not milligrams of gluten, that is essential in the treatment of celiac disease. Nutr Rev (2004) 0.78
Modeling of celiac disease immune response and the therapeutic effect of potential drugs. BMC Syst Biol (2013) 0.77